Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.

Mendelsohn AH, Berke GS.

Ann Otol Rhinol Laryngol. 2012 Apr;121(4):231-8.

PMID:
22606926
2.

Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.

Simpson CB, Lee CT, Hatcher JL, Michalek J.

Laryngoscope. 2016 Jan;126(1):118-21. doi: 10.1002/lary.25515. Epub 2015 Oct 15.

PMID:
26467807
3.

A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.

Morzaria S, Damrose EJ.

J Voice. 2012 May;26(3):378-80. doi: 10.1016/j.jvoice.2010.07.011. Epub 2010 Oct 16.

PMID:
20951552
4.

Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.

Kendall KA, Leonard RJ.

J Voice. 2011 Jan;25(1):114-9. doi: 10.1016/j.jvoice.2009.08.003. Epub 2010 Feb 4.

PMID:
20137891
5.

Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.

Tsuji DH, Takahashi MT, Imamura R, Hachiya A, Sennes LU.

J Voice. 2012 Sep;26(5):666.e7-12. doi: 10.1016/j.jvoice.2011.07.009. Epub 2011 Sep 22.

PMID:
21940146
6.

Voice handicap index results for older patients with adductor spasmodic dysphonia.

Wingate JM, Ruddy BH, Lundy DS, Lehman J, Casiano R, Collins SP, Woodson GE, Sapienza C.

J Voice. 2005 Mar;19(1):124-31.

PMID:
15766857
7.

Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment.

Langeveld TP, van Rossum M, Houtman EH, Zwinderman AH, Briaire JJ, Baatenburg de Jong RJ.

Ann Otol Rhinol Laryngol. 2001 Jul;110(7 Pt 1):627-34.

PMID:
11465821
8.

Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes.

Novakovic D, Waters HH, D'Elia JB, Blitzer A.

Laryngoscope. 2011 Mar;121(3):606-12. doi: 10.1002/lary.21395. Epub 2011 Feb 4.

PMID:
21298641
9.

Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia.

Rosow DE, Parikh P, Vivero RJ, Casiano RR, Lundy DS.

Otolaryngol Head Neck Surg. 2013 Jun;148(6):1003-6. doi: 10.1177/0194599813484685. Epub 2013 Mar 27.

PMID:
23535709
10.

Speech intelligibility in severe adductor spasmodic dysphonia.

Bender BK, Cannito MP, Murry T, Woodson GE.

J Speech Lang Hear Res. 2004 Feb;47(1):21-32.

PMID:
15072525
11.

Abductor paralysis after botox injection for adductor spasmodic dysphonia.

Venkatesan NN, Johns MM, Hapner ER, DelGaudio JM.

Laryngoscope. 2010 Jun;120(6):1177-80. doi: 10.1002/lary.20855.

PMID:
20513036
12.

Current practices in the management of adductor spasmodic dysphonia.

Eskander A, Fung K, McBride S, Hogikyan N.

J Otolaryngol Head Neck Surg. 2010 Oct;39(5):622-30.

PMID:
20828529
13.

Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.

Braden MN, Johns MM 3rd, Klein AM, Delgaudio JM, Gilman M, Hapner ER.

J Voice. 2010 Mar;24(2):242-9. doi: 10.1016/j.jvoice.2008.08.003. Epub 2009 May 28.

PMID:
19481417
14.

Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues.

Young DL, Halstead LA.

J Voice. 2014 Sep;28(5):614-7. doi: 10.1016/j.jvoice.2013.10.024. Epub 2014 Jun 18.

PMID:
24954039
15.

Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.

Orbelo DM, Duffy JR, Hughes Borst BJ, Ekbom D, Maragos NE.

J Voice. 2014 Jan;28(1):123-7. doi: 10.1016/j.jvoice.2013.05.008. Epub 2013 Sep 27.

PMID:
24080335
16.

Perceptual analyses of spasmodic dysphonia before and after treatment.

Cannito MP, Woodson GE, Murry T, Bender B.

Arch Otolaryngol Head Neck Surg. 2004 Dec;130(12):1393-9.

PMID:
15611398
17.

Treatment efficacy of electromyography versus fiberscopy-guided botulinum toxin injection in adductor spasmodic dysphonia patients: a prospective comparative study.

Kim JW, Park JH, Park KN, Lee SW.

ScientificWorldJournal. 2014;2014:327928. doi: 10.1155/2014/327928. Epub 2014 Oct 14.

18.

Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection.

Sapienza CM, Cannito MP, Murry T, Branski R, Woodson G.

J Speech Lang Hear Res. 2002 Oct;45(5):830-43.

PMID:
12381042
20.

Combined modality treatment of adductor spasmodic dysphonia.

Silverman EP, Garvan C, Shrivastav R, Sapienza CM.

J Voice. 2012 Jan;26(1):77-86. doi: 10.1016/j.jvoice.2010.08.004. Epub 2011 Feb 3.

PMID:
21292439
Items per page

Supplemental Content

Write to the Help Desk